A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations

Pharmacotherapy

Volumn 21, Issue 9 I, 2001, Pages 1107-1114

  Cannon, J P ^a   Garey, K W ^a   Danziger, L H ^a  

^a Chicago College of Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG TOLERANCE; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEPHROTOXICITY; PRESCRIPTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SHORT SURVEY; TREATMENT OUTCOME;

EID: 0034861678     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.13.1107.34613     Document Type: Short Survey

References (18)

1. The emergence of fungi as major hospital pathogens
2. Practice guidelines for the treatment of fungal infections
3. Epidemiology of nosocomial fungal infections, with emphasis on Candida species
4. A four-year review of fatal aspergillosis
5. Epidemiology of visceral mycoses: Analysis of data in annual of the pathological autopsy cases in Japan
6. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
7. Antifungal agents. Part I. Amphotericin B preparations and flucytosine
8. Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
9. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
10. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections
11. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: A single-centre experience of 133 episodes in 116 patients
12. An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis
13. Randomized study of two lipid formulations of amphotericin B in the treatment of suspected or documented fungal infections in patients with leukemia
14. A comparative analysis of lipid-complexed and liposomal amphotericin B preparations in haematological oncology
15. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia